Clinical Trials Logo

Recurrent Mature B-cell Neoplasms clinical trials

View clinical trials related to Recurrent Mature B-cell Neoplasms.

Filter by:
  • None
  • Page 1

NCT ID: NCT01704963 Completed - Clinical trials for Recurrent Mature B-cell Neoplasms

A Study to Evaluate the Bruton's Tyrosine Kinase (Btk) Inhibitor PCI-32765 in Patients With Recurrent Mature B-Cell Neoplasms

Start date: September 12, 2012
Phase: Phase 1
Study type: Interventional

The purpose of this study is to evaluate the safety and tolerability of Bruton's Tyrosine Kinase (Btk) Inhibitor PCI-32765 in Japanese patients with recurrent mature B-cell neoplasms.